StockNews.com Begins Coverage on Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB)
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research report released on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Stock Performance Shares of NYSEAMERICAN:NAVB opened at $0.10 on Wednesday. The stock has a 50 day moving average of $0.15 and a 200 […]